Soussain Carole, Ricard Damien, Fike John R, Mazeron Jean-Jacques, Psimaras Dimitri, Delattre Jean-Yves
INSERM, U975, Paris, France.
Lancet. 2009 Nov 7;374(9701):1639-51. doi: 10.1016/S0140-6736(09)61299-X.
Treatment-induced CNS toxicity remains a major cause of morbidity in patients with cancer. Advances in the design of safe radiation procedures have been counterbalanced by widespread use of combined radiotherapy and chemotherapy, development of radiosurgery, and the increasing number of long-term survivors. Although classic radionecrosis and chemonecrosis have become less common, subtle changes such as progressive cognitive dysfunction are increasingly reported after radiotherapy (radiation-induced leukoencephalopathy) or chemotherapy (given alone or in combination). We review the most important and controversial complications of radiotherapy, chemotherapy, and combined treatments in the CNS, and discuss new diagnostic tools, practical management, prevention, and pathophysiological data that will affect future management of patients with cancer.
治疗引起的中枢神经系统毒性仍然是癌症患者发病的主要原因。安全放疗程序设计方面的进展被放疗与化疗联合使用的广泛普及、立体定向放射外科的发展以及长期存活者数量的增加所抵消。尽管典型的放射性坏死和化学性坏死已变得不那么常见,但放疗(放射性白质脑病)或化疗(单独使用或联合使用)后越来越多地报告有渐进性认知功能障碍等细微变化。我们回顾了中枢神经系统放疗、化疗及联合治疗最重要且有争议的并发症,并讨论了将影响未来癌症患者管理的新诊断工具、实际管理、预防及病理生理学数据。